Rodney J Schlosser Selected Research

Cerebrospinal Fluid Leak

11/2017	Sinonasal T-cell expression of cytotoxic mediators granzyme B and perforin is reduced in patients with chronic rhinosinusitis.
2/2016	Fibroblast levels are increased in chronic rhinosinusitis with nasal polyps and are associated with worse subjective disease severity.
1/2016	Vitamin D deficiency is associated with increased human sinonasal fibroblast proliferation in chronic rhinosinusitis with nasal polyps.
7/2014	Passive smoke exposure in chronic rhinosinusitis as assessed by hair nicotine.
6/2006	Endoscopic management of cerebrospinal fluid rhinorrhea.
1/2005	Presence of surfactant lamellar bodies in normal and diseased sinus mucosa.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Rodney J Schlosser Research Topics

Disease

55	Rhinosinusitis 05/2022 - 01/2005
22	Nasal Polyps (Nasal Polyp) 05/2022 - 11/2004
13	Hypersensitivity (Allergy) 01/2022 - 07/2006
11	Polyps 01/2022 - 11/2004
10	Allergic Fungal Sinusitis 05/2022 - 01/2005
10	Asthma (Bronchial Asthma) 01/2022 - 07/2006
8	Allergic Rhinitis 03/2022 - 09/2008
6	Cerebrospinal Fluid Leak 11/2017 - 01/2005
6	Inflammation (Inflammations) 01/2017 - 09/2007
5	Sinusitis 06/2022 - 09/2006
5	Neoplasms (Cancer) 01/2022 - 01/2005
5	Encephalocele (Encephalocele, Frontal) 04/2020 - 08/2002
5	Cystic Fibrosis (Mucoviscidosis) 06/2010 - 01/2005
4	Pituitary Neoplasms (Pituitary Adenoma) 11/2017 - 07/2014
3	Anosmia 01/2021 - 12/2014
3	Mucocele 05/2011 - 05/2004
2	Rhinitis 01/2022 - 06/2009
2	Olfaction Disorders (Cacosmia) 01/2022 - 01/2021
2	Nasal Obstruction 01/2022 - 01/2021
2	COVID-19 03/2021 - 01/2021
2	Fatigue 01/2021 - 01/2019
2	Rhinorrhea 01/2021 - 01/2011
2	Cerebrospinal Fluid Rhinorrhea 01/2019 - 03/2009
2	Pneumocephalus 01/2017 - 08/2009
2	Infections 01/2017 - 03/2009
2	Obstructive Sleep Apnea 11/2015 - 04/2012
2	Otitis Media 01/2013 - 04/2012
2	Hypertrophy 10/2012 - 04/2012
2	Wounds and Injuries (Trauma) 01/2009 - 02/2005
2	Communicable Diseases (Infectious Diseases) 01/2007 - 07/2006
1	Postoperative Pain 06/2022
1	Headache (Headaches) 06/2022
1	Frailty 03/2022
1	Facial Pain (Myofacial Pain) 01/2021
1	Apnea 01/2021
1	Sleepiness 01/2021
1	Paramyxoviridae Infections (Parainfluenza) 11/2020
1	Abscess 08/2020
1	Pain (Aches) 01/2020

Drug/Important Bio-Agent (IBA)

9	Proteins (Proteins, Gene)FDA Link 03/2022 - 02/2005
7	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 05/2022 - 11/2013
7	Adrenal Cortex Hormones (Corticosteroids)IBA 03/2022 - 07/2014
7	Cholecalciferol (Vitamin D3)FDA Link 01/2022 - 10/2012
6	SteroidsIBA 01/2021 - 11/2004
6	SmokeIBA 01/2017 - 11/2009
5	Iron-Dextran Complex (InFed)FDA Link 01/2022 - 02/2016
5	CytokinesIBA 01/2017 - 11/2004
5	AntigensIBA 10/2012 - 09/2008
4	Anti-Bacterial Agents (Antibiotics)IBA 06/2022 - 09/2015
4	AllergensIBA 03/2022 - 06/2009
4	Immunoglobulin E (IgE)IBA 02/2010 - 09/2008
4	Surface-Active Agents (Surfactants)IBA 07/2007 - 01/2005
3	Hormones (Hormone)IBA 11/2017 - 01/2016
3	Pulmonary Surfactant-Associated Protein D (Surfactant Protein D)IBA 09/2007 - 07/2006
2	Histamine Antagonists (Antihistamines)IBA 03/2022 - 11/2015
2	hydroxide ionIBA 01/2022 - 01/2017
2	Calcifediol (Calcidiol)FDA Link 01/2022 - 01/2016
2	Indicators and Reagents (Reagents)IBA 03/2021 - 01/2003
2	xhanceIBA 01/2021 - 01/2020
2	Oxygen (Dioxygen)IBA 01/2021 - 01/2005
2	EnzymesIBA 01/2021 - 10/2012
2	Biological ProductsIBA 01/2021 - 01/2020
2	Interleukin-13IBA 01/2020 - 11/2004
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2020 - 09/2007
2	Interleukin-5 (Interleukin 5)IBA 01/2020 - 11/2004
2	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2013 - 11/2009
2	Pharmaceutical PreparationsIBA 03/2012 - 01/2009
2	ChemokinesIBA 07/2011 - 11/2004
2	Complement Factor B (Factor B)IBA 07/2010 - 01/2010
2	MucinsIBA 09/2008 - 01/2005
2	Phospholipids (Phosphatides)FDA LinkGeneric 09/2006 - 01/2005
1	Vitamin A (Retinol)FDA LinkGeneric 03/2022
1	SeleniumIBA 03/2022
1	Carotenoids (Carotene)IBA 03/2022
1	Calcitriol (Calcijex)FDA LinkGeneric 01/2022
1	salicylhydroxamic acid (SHAM)IBA 01/2022
1	mepolizumabIBA 01/2022
1	VaccinesIBA 01/2021
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	Carrier Proteins (Binding Protein)IBA 01/2021
1	ProteomeIBA 01/2021
1	Nucleic AcidsIBA 11/2020
1	Aligeron (AS 2)IBA 04/2020
1	Interleukin-9 (Interleukin 9)IBA 01/2020
1	Interleukin-6 (Interleukin 6)IBA 01/2020
1	Interleukin-10 (Interleukin 10)IBA 01/2020
1	LigandsIBA 01/2020

Therapy/Procedure

17	Therapeutics 03/2022 - 06/2010
4	Immunotherapy 03/2022 - 09/2011
3	Drug Therapy (Chemotherapy) 06/2022 - 01/2005
3	Reoperation 01/2020 - 01/2019
3	Length of Stay 01/2017 - 03/2007
3	Adenoidectomy 07/2014 - 04/2012
3	Craniotomy 03/2009 - 05/2004
3	Postoperative Care 06/2006 - 08/2002
2	Aftercare (After-Treatment) 04/2016 - 01/2007
2	Surgical Flaps 05/2011 - 09/2009
1	Local Anesthesia 01/2022
1	Cryotherapy (Therapy, Cold) 01/2022
1	Conservative Treatment 08/2020